MiMedx develops placental tissue allografts for various healthcare sectors. The company uses its patented PURION process to retain biological properties and regulatory proteins. Products include EpiFix, AmnioFix, EpiCord, and AmnioCord for wound care, burn, and surgical recovery. These products are sold through direct sales force, independent agents, and distributors in the US. MiMedx was incorporated in 2011 and is headquartered in Marietta, Georgia. The company processes placental tissues using aseptic techniques and terminal sterilization. Its products have applications in wound care, burn, and surgical sectors of healthcare.
Indicator | Value |
---|---|
PER | 22.2 |
EV/EBITDA | 13.2 |
Price/Free Cash Flow' | 14.6 |
ROIC | 31.2% |
Net Debt/EBITDA | 100.0 |